You have 9 free searches left this month | for more free features.

City

Condition

TNBC - Triple-Negative Breast Cancer (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Fudan University (1)

Collaborator

Intervention

epirubicin,cyclophosphamide,paclitaxel (1)

epirubicin,cyclophosphamide,paclitaxel,carrelizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

epirubicin,cyclophosphamide,paclitaxel

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

Not yet recruiting

TNBC - Triple-Negative Breast Cancer

epirubicin,cyclophosphamide,paclitaxel,Carrelizumab
epirubicin,cyclophosphamide,paclitaxel

(no location specified)

May 8, 2023